InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Landry Robert E, Chief Financial Officer. Officer active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 30 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. History available since 6 August 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Landry Robert E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
2,851 shares0Common StockSEC:0001061983-26-000056:0
7,333 shares0Common StockSEC:0001127602-25-014356:0
400 shares@ US$378.980.7% of flowCommon StockSEC:0001968202-24-000053:0
400 shares@ US$378.980.7% of flowCommon StockSEC:0001968202-24-000045:0
1,100 shares@ US$378.981.9% of flowCommon StockSEC:0001968202-24-000040:0
500 shares@ US$378.980.9% of flowCommon StockSEC:0001968202-24-000036:0
800 shares@ US$378.981.4% of flowCommon StockSEC:0001968202-24-000034:0
500 shares@ US$378.980.8% of flowCommon StockSEC:0001968202-24-000031:0
650 shares@ US$378.981.1% of flowCommon StockSEC:0001883850-24-000005:0
750 shares@ US$378.981.3% of flowCommon StockSEC:0001883850-23-000108:0
6,381 shares@ US$856.7124.9% of flowCommon StockSEC:0001883850-23-000100:0
1,013 shares@ US$843.793.9% of flowCommon StockSEC:0001968202-23-000051:0
223 shares@ US$844.000.8% of flowCommon StockSEC:0001968202-23-000030:0
800 shares@ US$381.921.4% of flowCommon StockSEC:0001968202-23-000004:0
739 shares@ US$764.502.5% of flowCommon StockSEC:0001883850-23-000035:0
3,853 shares0Common StockSEC:0001883850-22-000132:0
3,000 shares@ US$381.925.3% of flowCommon StockSEC:0001883850-22-000107:0
2,500 shares@ US$381.924.5% of flowCommon StockSEC:0001883850-22-000102:0
2,000 shares@ US$381.923.8% of flowCommon StockSEC:0001883850-22-000086:0
1,500 shares@ US$381.922.9% of flowCommon StockSEC:0001883850-22-000082:0
1,500 shares@ US$399.663.2% of flowCommon StockSEC:0001883850-22-000040:0
1,500 shares@ US$399.663.1% of flowCommon StockSEC:0001883850-22-000028:0
1,250 shares@ US$555.673.7% of flowCommon StockSEC:0001883850-22-000022:0
300 shares@ US$693.001.1% of flowCommon StockSEC:0001708138-22-000028:0
300 shares@ US$677.001.1% of flowCommon StockSEC:0001708138-22-000022:0
25 of 30 declarations
About Landry Robert E
Landry Robert E is Chief Financial Officer. He has 30 filings in total, and across the 30 sampled filings between 2021-08-10 and 2026-05-27, buys are 0 and sells are 1064702 EUR, with Levée d'options as the most frequent transaction nature. He is also linked to Regeneron Pharmaceuticals, INC. as EVP Finance CFO and to CYTOKINETICS INC as Director.
